Purchases and Sales Made in Q4 2022 in Sonoma Pharmaceuticals, Inc. (SNOA)
This table provides information about the institutional ownership of Sonoma Pharmaceuticals, Inc. (SNOA) during Q4 2022. The information is specifically focused on institutions that hold shares of Sonoma Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
16.6KNew |
$16.8K - $893K
|
16.6K
$42.8K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.15K+ 64.12% |
$3.18K - $169K
|
8.06K
$20.8K
|
|
Feb 06, 2023
Q4 2022
|
New Square Capital LLC
|
BUY
|
- |
10New |
$10.1 - $538
|
10
$25.8
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-123- 0.33% |
$124 - $6.62K
|
36.8K
$94.8K
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-900- 1.19% |
$909 - $48.4K
|
74.5K
$192K
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-2.58K- 46.87% |
$2.61K - $139K
|
2.93K
$7.55K
|